Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Immunology

• Publication date

  2001-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1521-4141(2001010)31:10<2942::AID-IMMU2942>3.0.CO;2-MPMID 11592070PMCID PMC11956759
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions

  2004cited by this paper
• Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis

  2001cited by this paper
• Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide

  2001cited by this paper
• Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells

  2000cited by this paper
• Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24–36 Is Presented by a Monomorphic MHC Class II Molecule1

  2000cited by this paper
• Limiting dilution analysis: from frequencies to cellular interactions.

  2000cited by this paper
• Human Nerve Growth Factor Protects Common Marmosets against Autoimmune Encephalomyelitis by Switching the Balance of T Helper Cell Type 1 and 2 Cytokines within the Central Nervous System

  2000cited by this paper
• Development of Myelin Oligodendrocyte Glycoprotein Autoreactive Transgenic B Lymphocytes: Receptor Editing In Vivo After Encounter of a Self-Antigen Distinct from Myelin Oligodendrocyte Glycoprotein

  2000cited by this paper
• Regulatory T cells in autoimmmunity*.

  2000cited by this paper
• High Frequency of Autoreactive Myelin Proteolipid Protein–Specific T Cells in the Periphery of Naive Mice

  2000cited by this paper
• Identification of autoantibodies associated with myelin damage in multiple sclerosis

  1999cited by this paper
• Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice.

  1999cited by this paper
• B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide

  1999cited by this paper
• The Structure and Function of Myelin Oligodendrocyte Glycoprotein

  1999cited by this paper
• Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.

  1999cited by this paper
• IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice.

  1999cited by this paper
• Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen‐specific antibody mediation

  1999cited by this paper
• Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein.

  1999cited by this paper
• Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis.

  1999cited by this paper
• Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein.

  1998cited by this paper
• Fine specificities of T cell and B cell responses to myelin/oligodendrocyte glycoprotein in common marmosets

  1998cited by this paper
• The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis

  1998cited by this paper
• Myelin protein expression in lymphoid tissues: implications for peripheral tolerance

  1998cited by this paper
• B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

  1998cited by this paper
• Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives.

  1997cited by this paper
• Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide.

  1997cited by this paper
• Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques.

  1997cited by this paper
• Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions

  1997cited by this paper
• Direct Ex Vivo Analysis of Activated, Fas-sensitive Autoreactive T Cells in Human Autoimmune Disease

  1997cited by this paper
• Allergic Encephalomyelitis in Common Marmosets: Pathogenesis of a Multiple Sclerosis-like Lesion

  1996cited by this paper
• Lymphocyte Targeting of the Central Nervous System: A Review of Afferent and Efferent CNS‐Immune Pathways

  1996cited by this paper
• Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.

  1996cited by this paper
• Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse Vβ gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor Vβb and T cell receptor Vβa H‐2b mice

  1996cited by this paper
• Mechanisms of Immune Injury in Multiple Sclerosis

  1996cited by this paper
• Late Complications of Immune Deviation Therapy in a Nonhuman Primate

  1996cited by this paper
• Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases

  1995cited by this paper
• Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein

  1995cited by this paper
• Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.

  1995cited by this paper
• The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.

  1995cited by this paper
• Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)‐derived peptide: Preliminary analysis of MOG T cell epitopes

  1995cited by this paper
• In healthy primates, circulating autoreactive T cells mediate autoimmune disease.

  1994cited by this paper
• Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice.

  1994cited by this paper
• T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system

  1993cited by this paper
• Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity.

  1993cited by this paper
• The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease

  1993cited by this paper
• Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.

  1993cited by this paper
• The T‐cell response to myelin basic protein in familial multiple sclerosis: Diversity of fine specificity, restricting elements, and T‐cell receptor usage

  1993cited by this paper
• Myelin basic protein–specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity

  1992cited by this paper
• Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily

  1992cited by this paper
• The cognitive principle challenges clonal selection.

  1992cited by this paper
• Frequency of T cells specific for myelin basic protein and myelin proteolipid protein in blood and cerebrospinal fluid in multiple sclerosis.

  1992cited by this paper
• Autoimmunity, microbial immunity and the immunological homunculus.

  1991cited by this paper
• T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.

  1991cited by this paper
• Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.

  1990cited by this paper
• The T lymphocyte in experimental allergic encephalomyelitis.

  1990cited by this paper
• Differential Ultrastructural Localization of Myelin Basic Protein, Myelin/Oligodendroglial Glycoprotein, and 2′,3′‐Cyclic Nucleotide 3′‐Phosphodiesterase in the CNS of Adult Rats

  1989cited by this paper
• Suppression of experimentally induced autoimmune encephalomyelitis by cytolytic T–T cell interactions

  1988cited by this paper
• A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.

  1987cited by this paper
• Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations.

  1985cited by this paper
• Encephalomyelitis Experimental Autoimmune Oligodendrocyte Glycoprotein in Encephalitogenic T Cell Response to Myelin Butyrophilin, a Milk Protein, Modulates The

  year unknowncited by this paper

• Protection against autoimmunity is driven by thymic epithelial cell–mediated regulation of Treg development

  2021cites this paper
• Animal Models of Multiple Sclerosis

  2021cites this paper
• Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies

  2021cites this paper
• A Tolerogenic Role of Cathepsin G in a Primate Model of Multiple Sclerosis: Abrogation by Epstein–Barr Virus Infection

  2020cites this paper
• A Tolerogenic Role of Cathepsin G in a Primate Model of Multiple Sclerosis: Abrogation by Epstein-Barr Virus Infection.

  2020cites this paper
• Immunologie de la sclérose en plaques

  2019cites this paper
• Role of Twist1 in metabolism of repeatedly stimulated Th1 cells

  2019cites this paper
• Experimental Autoimmune Encephalomyelitis in the Marmoset as a Translational Model for Multiple Sclerosis

  2019cites this paper
• Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial

  2019cites this paper
• Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

  2019cites this paper
• Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery

  2018cites this paper
• A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model

  2017cites this paper
• Autoimmune encephalomyelitis Model

  2017cites this paper
• The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.

  2016cites this paper
• The primate autoimmune encephalomyelitis model; a bridge between mouse and man

  2015cites this paper
• Modeling and Analysis of Recurrent Autoimmune Disease

  2014cites this paper
• Modeling MS in Nonhuman Primates

  2013cites this paper
• Chronic autoimmune-mediated inflammation: a senescent immune response to injury.

  2013cites this paper
• Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice

  2013cites this paper
• The Primate EAE Model Points at EBV-Infected B Cells as a Preferential Therapy Target in Multiple Sclerosis

  2013influential citation
• The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model

  2013cites this paper
• GEMSP exerts a myelin-protecting role in the rat optic nerve

  2013cites this paper
• Nervous System Disorders of Nonhuman Primates and Research Models

  2012cites this paper
• Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys

  2012cites this paper
• Erratum to: Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys

  2012cites this paper
• Mechanistic refinement of the common marmoset model for multiple sclerosis

  2012cites this paper
• Modeling the effector - regulatory T cell cross-regulation reveals the intrinsic character of relapses in Multiple Sclerosis

  2011influential citation
• Modelling of Autoimmune Encephalomyelitis in a Non-Human Primate

  2011cites this paper
• Clinical, Pathological, and Immunologic Aspects of the Multiple Sclerosis Model in Common Marmosets (Callithrix jacchus)

  2009cites this paper
• Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.

  2008cites this paper
• Spontaneous and Experimentally Induced Autoimmune Diseases in Nonhuman Primates

  2008cites this paper
• Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development

  2008cites this paper
• Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34–56-Specific Cytotoxic T Cells1

  2008cites this paper
• Autoimmunity Against Myelin Oligodendrocyte Glycoprotein Is Dispensable for the Initiation Although Essential for the Progression of Chronic Encephalomyelitis in Common Marmosets

  2008cites this paper
• Evaluation of the effects of a new drug candidate (GEMSP) in a chronic EAE model

  2008cites this paper
• Non-human primate models of multiple sclerosis

  2008cites this paper
• IL‐10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis

  2008cites this paper
• Associated with the Activation of MOG Encephalomyelitis in Marmosets Is ( MOG )-Induced Experimental Autoimmune Myelin / Oligodendrocyte Glycoprotein Fast Progression of Recombinant

  2008cites this paper
• Preclinical Assessment of Therapeutic Antibodies against Human CD40 and Human Interleukin-12/23p40 in a Nonhuman Primate Model of Multiple Sclerosis

  2007cites this paper
• Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF

  2007cites this paper
• Organ specific autoantigens and the autoreactiveT cell repertoire: The case of myelin oligodendrocyte glycoprotein

  2006cites this paper
• Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates.

  2006cites this paper
• Immunopathology and Infectious Disease Phagocytes Containing a Disease-Promoting Toll-Like Receptor/Nod Ligand Are Present in the Brain during Demyelinating Disease in Primates

  2006cites this paper
• Methylthioadenosine reverses brain autoimmune disease

  2006cites this paper
• Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.

  2006cites this paper
• Non-human primate models of experimental autoimmune encephalomyelitis: Variations on a theme.

  2005cites this paper
• Treatment with chimeric anti-human CD40 antibody suppresses MRI-detectable inflammation and enlargement of pre-existing brain lesions in common marmosets affected by MOG-induced EAE.

  2005cites this paper
• Experimental Autoimmune Encephalomyelitis in Primates

  2005cites this paper
• Immune modulation in MS models by peptidoglycan, CD97 and CD44

  2005cites this paper
• Commentary: Sorting the wheat from the chaff: identifying demyelinating components of the myelin oligodendrocyte glycoprotein (MOG)‐specific autoantibody repertoire

  2004cites this paper
• Yin–Yang regulation of autoimmunity by DCs

  2004cites this paper
• Modelling of multiple sclerosis: lessons learned in a non-human primate.

  2004cites this paper
• Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines

  2004cites this paper
• GB virus B infection of the common marmoset (Callithrix jacchus) and associated liver pathology.

  2004cites this paper
• Yin-Yang regulation of autoimmunity by DCs.

  2004cites this paper
• Functional properties of myelin oligodendrocyte glycoprotein-reactive T cells in multiple sclerosis patients and controls.

  2003cites this paper
• Patients with Rheumatoid Arthritis Ribonucleoprotein A 2 ( RA 33 ) and Filaggrin the Autoantigens Heterogeneous Nuclear Characterization of Autoreactive T Cells to

  2002cites this paper
• Characterization of Autoreactive T Cells to the Autoantigens Heterogeneous Nuclear Ribonucleoprotein A2 (RA33) and Filaggrin in Patients with Rheumatoid Arthritis1

  2002cites this paper
• Myelin Oligodendrocyte Gene Polymorphisms and Childhood Multiple Sclerosis

  2002cites this paper
• Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination

  2002cites this paper
• The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study1

  2002cites this paper
• Oligodendrocyte Glycoprotein: A Multiple The Human T Cell Response to Myelin

  2002cites this paper
• Immune Responses Against the Myelin/Oligodendrocyte Glycoprotein in Experimental Autoimmune Demyelination

  2001cites this paper
• In Patients with Rheumatoid Arthritis Ribonucleoprotein A2 (ra33) and Filaggrin the Autoantigens Heterogeneous Nuclear Characterization of Autoreactive T Cells To

  year unknowncites this paper